Showing results (121-130 of 147) with videos related to
Sort By:
Pageof 15
Journal of Gastroenterology and Hepatology|August 1, 1997
Prolonged bleeding time: a new clinical manifestation of hepatocellular carcinoma?C J Chu, E Y Lee, S J Hwang, et al.Scandinavian Journal of Gastroenterology|September 23, 1997
Prognostic value of plasma endotoxin levels in patients with cirrhosisC C Chan, S J Hwang, F Y Lee, et al.Current Radiopharmaceuticals|June 18, 2010
Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-LigandsIn Soo Shin, Jin Soo Maeng, Beom-Su Jang, et al.British Journal of Cancer|October 7, 2010
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancerC-P Li, J-S Chen, L-T Chen, et al.British Journal of Cancer|June 29, 2006
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancerY Chao, C P Li, T Y Chao, et al.The American Journal of Gastroenterology|November 15, 1997
Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamicsF Y Lee, H C Lin, Y T Tsai, et al.Plant Cell Reports|June 6, 2003
Characterisation of the expression of a novel constitutive maize promoter in transgenic wheat and maizeS Rasco-Gaunt, D Liu, C P Li, et al.Journal of Gastroenterology and Hepatology|June 1, 1997
Gall-bladder wall thickening in patients with liver cirrhosisT F Wang, S J Hwang, E Y Lee, et al.Cancer|August 27, 1999
Paraneoplastic syndromes in patients with hepatocellular carcinoma in TaiwanJ C Luo, S J Hwang, J C Wu, et al.Scandinavian Journal of Gastroenterology|May 1, 1996
Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulationF Y Lee, R H Lu, Y T Tsai, et al.Pageof 15